文献速递乳腺癌支持与姑息治疗

放疗对乳腺癌生存者1年疲劳的影响:前瞻性多中心CANcer TOxicity队列研究

Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort.
PubMed 文献 · Eur J Cancer · 2022-10-10

在CANTO-RT前瞻性多中心队列3295例I-III期乳腺癌患者中,评估放疗方式与放疗完成后1年严重疲劳的关联;严重整体疲劳患病率为33.3%,内乳链放疗和常规分割放疗与严重整体疲劳风险升高相关。

要点

  • 放疗后1年严重整体疲劳患病率为33.3%(EORTC QLQ-C30评分≥40/100)。
  • 内乳链放疗较未行内乳链放疗与严重整体疲劳风险升高相关(校正OR 1.48)。
  • 常规分割放疗较超分割放疗与严重整体疲劳(校正OR 1.88)和严重躯体疲劳(校正OR 1.849)风险升高相关。

核心结论

  • 内乳链放疗(对照为未行内乳链放疗)和常规分割放疗(对照为超分割放疗)与持续性严重整体疲劳风险升高显著相关。
  • 数据增进了对乳腺癌治疗后疲劳相关治疗因素的理解,可能有助于个体化干预以改善这一致残性症状的预防和管理。

研究设计与样本

  • CANTO-RT为CANcer TOxicity(CANTO;NCT01993498)的子队列,系2012至2017年治疗的多中心全国前瞻性I-III期乳腺癌队列。
  • 最终分析队列纳入3295例患者。
  • 主要结局为放疗完成后1年严重整体疲劳(EORTC QLQ-C30评分≥40/100)。
  • 次要结局包括严重躯体、情感和认知疲劳(EORTC QLQ-FA12)。
  • 采用多变量逻辑回归模型评估放疗相关变量与疲劳的关联。

主要发现

  • 治疗1年后严重整体疲劳患病率为33.3%。
  • 内乳链放疗与严重整体疲劳风险升高相关(校正OR 1.48,95%CI 1.03-2.13;p=0.0355)。
  • 常规分割放疗与严重整体疲劳风险升高相关(校正OR 1.88,95%CI 1.06-3.31;p=0.0298)。
  • 常规分割放疗与严重躯体疲劳可能性升高显著相关(校正OR 1.849,95%CI 1.04-3.3;p=0.0354)。

关键数值与推荐

  • 严重整体疲劳定义:EORTC QLQ-C30评分≥40/100。
  • 内乳链放疗 vs 未行内乳链放疗:校正OR 1.48(95%CI 1.03-2.13;p=0.0355)。
  • 常规分割放疗 vs 超分割放疗:校正OR 1.88(95%CI 1.06-3.31;p=0.0298)。
  • 常规分割放疗 vs 超分割放疗与严重躯体疲劳:校正OR 1.849(95%CI 1.04-3.3;p=0.0354)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fatigue is a common and disabling symptom after breast cancer (BC) treatment, significantly impacting patients' quality of life. We aimed to assess the impact of radiation therapy (RT) modalities on fatigue one year after treatment among patients with early-stage BC. METHODS: We used CANTO-RT, a subcohort of CANcer TOxicity (CANTO; NCT01993498), a multicentric nationwide prospective cohort of stages I-III BC treated from 2012 to 2017. Our primary outcome was severe global fatigue 1 year after RT completion (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 score ≥40/100). The secondary outcomes included severe physical, emotional and cognitive fatigue (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-FA12). RT-related variables were used as independent variables. Multivariable logistic regression models assessed associations between RT-related variables and fatigue. RESULTS: The final analytic cohort included 3295 patients. The prevalence of severe global fatigue 1 year after treatment was 33.3%. Internal mammary chain RT (adjusted odds ratio [OR] 1.48 [95% confidence interval [CI] 1.03-2.13; p = 0.0355]) and normofractionated RT (adjusted OR 1.88 [95% CI 1.06-3.31; p = 0.0298]) were associated with increased odds of severe global fatigue. In addition, there was a significant association between normofractionated RT (adjusted OR 1.849 [95% CI 1.04-3.3; p = 0.0354]) and an increased likelihood of severe physical fatigue. CONCLUSION: We found a significant association between internal mammary chain RT (versus No), normofractionated RT (versus hypofractionated RT) and increased likelihood of persistent severe global fatigue. Our data add to the current understanding of treatment-related factors affecting fatigue after BC and could lead to personalised interventions to improve the prevention and management of this disabling symptom.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Ghannam Y, Di Meglio A, Sarrade T, et al. Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort. Eur J Cancer. 2022. PMID: 36356418. doi:10.1016/j.ejca.2022.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。